Format

Send to

Choose Destination
J Thorac Dis. 2014 Aug;6(8):1024-31. doi: 10.3978/j.issn.2072-1439.2014.04.27.

Pediatric lung transplantation: indications and outcomes.

Author information

1
Section of Pulmonary Medicine, Lung and Heart-Lung Transplant Program, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA.

Abstract

Lung transplantation (LTx) is a treatment option for infants and children with untreatable and otherwise fatal pulmonary diseases. To date, over 1,800 lung transplants have been performed, most frequently in children over the age of five years. The most common indications for transplantation in children overall are cystic fibrosis (CF) and idiopathic pulmonary hypertension (PH). The surfactant protein deficiencies, other interstitial lung diseases (ILDs), and congenital heart disease are important indications among young children and infants. Re-transplantation is an option for selected recipients with chronic allograft rejection. Overall survival following pediatric LTx is similar to that encountered in adult patients, with recent registry data indicating a median survival of 4.9 years. Other outcomes such as the incidence of bronchiolitis obliterans (BO) and the presence of key post-transplant co-morbid conditions are also similar to the experience in adult lung transplant recipients.

KEYWORDS:

Lung transplantation (LTx); indications; infants; pediatrics; survival

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center